SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma.

Front Immunol · 2022 · PMC9424497 · PMID 36052090

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

did not reach statistical significancep=0.063so close (0.05 < p ≤ 0.1)

Although the difference of Kaplan–Meier survival curves did not reach statistical significance (p=0.063), there was a trend towards better OS with immunotherapy in high SIRGs group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.